Figure 2From: Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy Exploratory survival analysis with classification of patients in five groups according to the number of risk alleles as defined after the primary survival analysis. Back to article page